Rosenblatt Securities analyst Sean Horgan maintained a Sell rating on CME Group (NASDAQ:CME) on Thursday, setting a price target of $164, which is approximately 11.05% below the present share price of $184.37.
Horgan expects CME Group to post earnings per share (EPS) of $1.18 for the first quarter of 2021.
The current consensus among 11 TipRanks analysts is for a Hold rating of shares in CME Group, with an average price target of $189.7.
The analysts price targets range from a high of $219 to a low of $134.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $1.1 billion and a net profit of $515 million. The company's market cap is $66.19 billion.
According to TipRanks.com, Rosenblatt Securities analyst Sean Horgan is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 10.2% and a 63.89% success rate.
CME Group, Inc. operates as a security and commodity exchange company. It provides the risk management and investment needs of customers around the globe. The company offers a wide range of products across various asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. CME Group brings buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City. The company also provides clearing and settlement services for exchange-traded contracts, as well as for cleared over-the-counter derivatives transactions. It also offers market data services-including live quotes, delayed quotes, market reports and a comprehensive historical data service and has expanded into the index services business through CME Group Index Services. CME Group was founded in 1898 and is headquartered in Chicago, IL.